on 11 Jun 2020
Last Applicant/ Owned by
Horizon Discovery Limited
8100 Cambridge Research Park, Waterbeach Cambridge CB25 9TL
, ,
Serial Number
UK00801546358 filed on 11th Jun 2020
Registration Number
UK00801546358 registered on
7th Jan 2021
Correspondent Information
Stratagem Intellectual Property Management Limited
Meridian Court, Comberton Road, Toft Cambridge CB23 2RY
,
Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and commercial use.
Diagnostic preparations and materials generated by the use of base editing components; chemical preparation for use in DNA analysis (medical); DNA, RNA and parts thereof; DNA extracts; DNA reference standards; DNA reference libraries being collections of DNA and gene sequences; gene editing enzymes; protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical and commercial use; all the aforesaid goods being medical preparations.
Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services.
Custom cell-line engineering services; base-editing services; gene engineering services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines; creating libraries or collections of normal and mutated genes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies.
UK00801546358
Word
Individual